Saroglitazar in patients with non-alcoholic fatty liver disease and diabetic dyslipidemia: a prospective, observational, real world study
… lifestyle interventions, which are difficult to achieve and sustain by most of the patients3. The prime end-point for efficacy of pharmacological interventions … Saroglitazar in Indian diabetic …..... Read More